Literature DB >> 2550934

Loss of heterozygosity on chromosome 1q in human breast cancer.

L C Chen1, C Dollbaum, H S Smith.   

Abstract

Cytogenetic markers involving the long arm of chromosome 1 are the most frequently observed karyotypic changes seen in breast cancer. Based on cytogenetic data, we have used polymorphic DNA markers to search for allelic losses at this chromosome region among 48 breast carcinomas. For SPTA1, allelic losses were seen in 6 of 26 (23%) informative carcinomas, while 3 of 13 (23%) and 5 of 19 (26%) informative patients showed losses at AT3 and D1S53, respectively. The background frequency of allelic loss was obtained from data using 3 other loci on the 1q arm and 2 on the p arm of chromosome 1. With these markers, only 6 of 62 informative patients (8%) showed an allelic loss, with the range being 0-13%. The allelic losses seen on 1q, which were found in 9 carcinomas, comprised an overlapping set; the common region deleted was approximately 26 centimorgans on the q arm of chromosome 1 (bands q23-32 between AT3 and D1S53). These results suggest that inactivation of a gene(s) located on 1q23-32 might contribute to the genesis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550934      PMCID: PMC298025          DOI: 10.1073/pnas.86.18.7204

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Human breast carcinomas: marker chromosomes involving 1q in seven cases.

Authors:  Q V Cruciger; S Pathak; R Cailleau
Journal:  Cytogenet Cell Genet       Date:  1976

2.  In Reply: Amplification c-erbB-2 and Aggressive Human Breast Tumors?

Authors:  D J Slamon; G M Clark
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

3.  Allele loss on short arm of chromosome 17 in breast cancers.

Authors:  J Mackay; C M Steel; P A Elder; A P Forrest; H J Evans
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

4.  Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells.

Authors:  R Zhang; J Wiley; S P Howard; L F Meisner; M N Gould
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

5.  A genetic linkage map of the human genome.

Authors:  H Donis-Keller; P Green; C Helms; S Cartinhour; B Weiffenbach; K Stephens; T P Keith; D W Bowden; D R Smith; E S Lander
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

6.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

7.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

9.  Infrequent loss of chromosomal heterozygosity in human stomach cancer.

Authors:  M Wada; J Yokota; H Mizoguchi; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

10.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

Authors:  J Yokota; M Wada; Y Shimosato; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  26 in total

1.  Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.

Authors:  S W Lee; C Tomasetto; K Swisshelm; K Keyomarsi; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

3.  A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.

Authors:  Masataka Nakano; Tatsuki Fukami; Saki Gotoh; Miki Nakajima
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

4.  A novel zinc finger gene on human chromosome 1qter that is alternatively spliced in human tissues and cell lines.

Authors:  M Saleh; L Selleri; G A Evans
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

5.  A gene involved in control of human cellular senescence on human chromosome 1q.

Authors:  P J Hensler; L A Annab; J C Barrett; O M Pereira-Smith
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

Review 6.  Chromosomal abnormalities in human breast cancer.

Authors:  W M Mars; G F Saunders
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

Review 7.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

8.  Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.

Authors:  Emilia Wiechec; Jens Overgaard; Eigil Kjeldsen; Lise Lotte Hansen
Journal:  Cell Oncol (Dordr)       Date:  2012-12-18       Impact factor: 6.730

9.  (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.

Authors:  J C Zenklusen; I Bièche; R Lidereau; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 10.  Molecular and cellular lesions associated with breast cancer progression.

Authors:  H S Smith; L C Chen; J L Ngo; B M Ljung
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.